Hochschulschrift
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2015
- Schlagwort
-
Nichtmedikamentöse Therapie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2017
- Urheber
-
Lee, Seungmin
- Beteiligte Personen und Organisationen
-
Kupatt, Christian
- URN
-
urn:nbn:de:bvb:19-203003
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Lee, Seungmin
- Kupatt, Christian
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2017
Ähnliche Objekte (12)
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
P17-08. Transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors
Influence of the SUMOylation pathway on adeno-associated virus vector transduction
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
P17-08. Transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors
Influence of the SUMOylation pathway on adeno-associated virus vector transduction
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
P17-08. Transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors